title: Serum type I collagen and N-terminal peptide of type III procollagen in chronic hepatitis. Relationship to liver histology and conventional liver tests.
abstract: The aim of this study was to compare serum N-terminal peptide of type III procollagen to aminotransferases and gamma-globulins as a marker for histological activity in patients with chronic hepatitis and to assess the role of type I collagen, a new serum marker, as a marker of fibrosis in these patients. Sixty patients with biopsy-proven chronic hepatitis were included in this study. Liver disease was virus B-related in 29, autoimmune in five, drug-induced in five, and of unknown etiology in 21. Each biopsy was independently assessed by two liver pathologists. Two histological scores, a score of activity and a score of fibrosis, were established. Serum N-terminal peptide of type III procollagen and type I collagen were assayed by liquid phase RIA. Significant correlations were noted between serum N-terminal peptide of type III procollagen and scores of activity (r = 0.70, p less than 10(-4)) and fibrosis (r = 0.45, p = 0.0005), and between serum type I collagen and scores of activity (r = 0.46, p = 0.0004) and fibrosis (r = 0.67, p less than 10(-4)). When the correlation between scores of activity and fibrosis (r = 0.52, p = 10(-4)) was considered by partial correlation, serum N-terminal peptide of type III procollagen was correlated with the score of activity (r = 0.63, p less than 10(-3)) but not with the score of fibrosis, and serum type I collagen was correlated with the score of fibrosis (r = 0.58, p less than 10(-3)), but not with the score of activity.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Service d'Hépato-Gastroentérologie, Hôpital Jean Verdier, Bondy, France.
authors.forename: J C
authors.initials: JC
authors.lastname: Trinchet
authors.forename: D J
authors.initials: DJ
authors.lastname: Hartmann
authors.forename: D
authors.initials: D
authors.lastname: Pateron
authors.forename: M
authors.initials: M
authors.lastname: Laarif
authors.forename: P
authors.initials: P
authors.lastname: Callard
authors.forename: G
authors.initials: G
authors.lastname: Ville
authors.forename: M
authors.initials: M
authors.lastname: Beaugrand
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000410:Alanine Transaminase / Q000097:blood; D002908:Chronic Disease; D003094:Collagen / Q000097:blood*; D005260:Female; D006505:Hepatitis / Q000097:blood* / Q000150:complications / Q000473:pathology; D006521:Hepatitis, Chronic / Q000097:blood* / Q000150:complications / Q000473:pathology; D006801:Humans; D008099:Liver / Q000473:pathology*; D008103:Liver Cirrhosis / Q000209:etiology / Q000473:pathology; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D010446:Peptide Fragments / Q000097:blood*; D011347:Procollagen / Q000097:blood*; D005719:gamma-Globulins / Q000378:metabolism
chemical_list: D010446:Peptide Fragments; D011347:Procollagen; D005719:gamma-Globulins; C041876:procollagen Type III-N-terminal peptide; D003094:Collagen; D000410:Alanine Transaminase